155 related articles for article (PubMed ID: 23160697)
1. Leptomeningeal metastasis in melanoma: a prospective clinical study of nine patients.
Pape E; Desmedt E; Zairi F; Baranzelli MC; Dziwniel V; Dubois F; Bonneterre J; Mortier L; Le Rhun E
In Vivo; 2012; 26(6):1079-86. PubMed ID: 23160697
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
[TBL] [Abstract][Full Text] [Related]
6. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.
Boogerd W; van den Bent MJ; Koehler PJ; Heimans JJ; van der Sande JJ; Aaronson NK; Hart AA; Benraadt J; Vecht ChJ
Eur J Cancer; 2004 Dec; 40(18):2726-33. PubMed ID: 15571954
[TBL] [Abstract][Full Text] [Related]
7. Current diagnosis and treatment of leptomeningeal metastasis.
DeAngelis LM
J Neurooncol; 1998; 38(2-3):245-52. PubMed ID: 9696379
[TBL] [Abstract][Full Text] [Related]
8. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
9. [Guideline 'Leptomeningeal metastases of solid tumours'].
Boogerd W; du Bois WF; Teepen JL; Rosenbrand CJ
Ned Tijdschr Geneeskd; 2007 Jan; 151(2):123-8. PubMed ID: 17315489
[TBL] [Abstract][Full Text] [Related]
10. Management of leptomeningeal malignancy.
Pentheroudakis G; Pavlidis N
Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal metastasis.
DeAngelis LM; Boutros D
Cancer Invest; 2005; 23(2):145-54. PubMed ID: 15813508
[TBL] [Abstract][Full Text] [Related]
12. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Barba D
J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
[TBL] [Abstract][Full Text] [Related]
13. Therapy of leptomeningeal metastasis in solid tumors.
Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
[TBL] [Abstract][Full Text] [Related]
14. Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
Le Rhun E; Taillibert S; Devos P; Zairi F; Turpin A; Rodrigues I; Cazin JL; Pierret MF; André C; Dubois F; Bonneterre J; Chamberlain MC
Anticancer Drugs; 2013 Nov; 24(10):1093-7. PubMed ID: 23962903
[TBL] [Abstract][Full Text] [Related]
15. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
Craig C
Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
[TBL] [Abstract][Full Text] [Related]
16. [Phase I study of intrathecal chemotherapy with NS-101 for leptomeningeal carcinomatosis in Japan].
Nakagawa H; Tamura M; Fukushima Y; Majima S; Yamada K
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1799-805. PubMed ID: 18030013
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.
Schaefer N; Rasch K; Moehlenbruch M; Urbach H; Stuplich M; Blasius E; Scheffler B; Herrlinger U; Glas M
Acta Oncol; 2011 Nov; 50(8):1260-2. PubMed ID: 21736503
[No Abstract] [Full Text] [Related]
18. Intrathecal liposomal cytarabine and leptomeningeal medulloblastoma relapse: a valuable therapeutic option.
Mastronuzzi A; Del Bufalo F; Iacono A; Secco DE; Serra A; Colafati GS; DE Ioris MA; Corsetti T
Anticancer Res; 2013 Aug; 33(8):3515-8. PubMed ID: 23898128
[TBL] [Abstract][Full Text] [Related]
19. Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment.
Cho KM; Kim YJ; Kim SH; Kim JW; Lee JO; Han JH; Lee KW; Kim JH; Kim CY; Bang SM; Kim IA; Kim JS; Lee JS
Anticancer Res; 2015 Oct; 35(10):5631-8. PubMed ID: 26408736
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal metastases--treatment results in 98 consecutive patients.
Pfeffer MR; Wygoda M; Siegal T
Isr J Med Sci; 1988; 24(9-10):611-8. PubMed ID: 3144516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]